Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
May have a role in a signaling pathway. Additionally we are shipping SASH1 Kits (4) and SASH1 Proteins (3) and many more products for this protein.
Showing 10 out of 70 products:
Human Polyclonal SASH1 Primary Antibody for IP, WB - ABIN439800
Ascano, Mukherjee, Bandaru, Miller, Nusbaum, Corcoran, Langlois, Munschauer, Dewell, Hafner, Williams, Ohler, Tuschl: FMRP targets distinct mRNA sequence elements to regulate protein expression. in Nature 2012
Show all 2 Pubmed References
Human Polyclonal SASH1 Primary Antibody for ICC, IF - ABIN439801
Weidmann, Touat-Hamici, Durand, Mueller, Chardonnet, Pionneau, Charlotte, Janssen, Verdugo, Cambien, Blankenberg, Tiret, Zeller, Ninio: SASH1, a new potential link between smoking and atherosclerosis. in Atherosclerosis 2015
Show all 2 Pubmed References
Human Monoclonal SASH1 Primary Antibody for ELISA, WB - ABIN565047
Zhou, Wei, Deng, Wang, Zai, Wang, Guo, Zhang, Zhong, He, Xing: SASH1 regulates melanocyte transepithelial migration through a novel G?s-SASH1-IQGAP1-E-Cadherin dependent pathway. in Cellular signalling 2013
findings suggested that SASH1 can be useful as a new prognostic marker and therapeutic target in cervical cancer patients.
Data show that SAM and SH3 domain containing 1 protein (SASH1) binds with mitogen-activated protein kinase kinase 2 (MAP2K2 (show MAP2K2 Antibodies)), and SASH1 mutations promote binding between SASH1 and MAP2K2 (show MAP2K2 Antibodies).
SASH1 is prognostic in breast cancer and could have subtype-dependent effects on breast cancer progression.
SASH1 may inhibit hepatocarcinoma cell invasion and metastasis through down-regulating the Shh (show SHH Antibodies)-Gli1 (show GLI1 Antibodies) and PI3K (show PIK3CA Antibodies)-AKT (show AKT1 Antibodies) pathways
Case Report: SASH1 missense mutation in a Chinese Family with multiple lentigines.
SASH1 acts through NOTCH1 (show NOTCH1 Antibodies) and its inhibitor DLK1 (show DLK1 Antibodies) in a three-dimensional model of lumenogenesis involving CEACAM1 (show CEACAM1 Antibodies).
SASH1 is cleaved by caspase-3 (show CASP3 Antibodies) following Ultraviolet C-induced apoptosis.
a novel p53 (show TP53 Antibodies)/POMC (show POMC Antibodies)/Galphas (show GNAS Antibodies)/SASH1 autoregulatory positive feedback loop is regulated by SASH1 mutations to induce pathological hyperpigmentation phenotype.
Overexpression of SASH1 inhibits TGF-beta1 (show TGFB1 Antibodies)-induced EMT (show ITK Antibodies).
Overexpression of SASH1 suppressed the expression of Shh (show SHH Antibodies).
SASH1 acts to assemble a signaling complex downstream of TLR4 (show TLR4 Antibodies) to activate early endothelial responses to receptor activation.
Not expressed in the investigated haematopoietic cell lines, while transcripts were found in whole splenic B-cells from both wild type and Btk (show BTK Antibodies)-defective mice.
May have a role in a signaling pathway. Could act as a tumor suppressor.
SAM and SH3 domain containing 1
, SAM and SH3 domain-containing protein 1-like
, SAM and SH3 domain-containing protein 1
, proline-glutamate repeat-containing protein
, putative adapter and scaffold protein 1